Professional Documents
Culture Documents
Engineering Biosynthetic Pathways To Generate Antitumor Compounds
Engineering Biosynthetic Pathways To Generate Antitumor Compounds
antitumor compounds
César Sánchez
Departamento de Biología Funcional
e Instituto Universitario de Oncología del
Principado de Asturias (IUOPA)
University of Oviedo
Spain
Antitumor natural products from actinomycetes
H
H3C H3C H3CO OH O N O
O HO O
HO O CH3
HO O
H
O OH OH
H3C O
O
OH OH O O N N
HO H
CH3 H3C Cl Cl
H3C O O
O HO O O
HO O
OH
H3C
O HO
OH
OH
MITHRAMYCIN OH O OH
OCH3
(inhibition of DNA replication/transcription)
Streptomyces argillaceus OVIEDOMYCIN REBECCAMYCIN
(induction of apoptosis) (inhibition of DNA topoisomerase I)
Streptomyces antibioticus Lechevalieria aerocolonigenes
OCH3
CH3 OOCCH3
O
HO CH3 OCH3 OH H
O H N O
O O CH3 CH3 CH3 CH3
O OH OH
H3C O
OH OH O OH O
H3C N N
H3C
H3C O
O HO
O O
NC H
HO O
O
CH3 COOH MeO
H3C
O
H3CCOO
NHCH3
HO
N N
H H
INDOLO[2,3-a]CARBAZOLE
Indolocarbazoles as antitumor drug leads
H
N H
O O N O
N N
H N N
Cl Cl
O
O OH H3C H
HO H3CO
OH NHCH3
OCH3
STAUROSPORINE
REBECCAMYCIN (inhibition of protein kinases)
Produced by Streptomyces longisporoflavus
(inhibition of DNA topoisomerase I)
and other actinomycetes
Produced by Lechevalieria aerocolonigenes
Indolocarbazole derivatives in clinical trials
OH H
Cancer N O
Parkinson’s disease
OH
HN H
N
N O
O O
N N S S
O
H3C H
HO N N OH N N
H H3CO O
H3C H
OH NCH3
O O HO
HO COOCH3
N(CH2CH3)2 OH
CEP-1347 (KT-7515)
OH
Midostaurin (PKC-412,
O N O Edotecarin 4’-N-benzoyl-staurosporine)
(J-107088) Diabetic retinopathy
H H
HO N O N H
O
N N O N O
H
Cl Cl
O OH
N N N N
HO N N
O O
OH H3C H H3C H
OCH3 H3CO HO
NHCH3 CH2OH O
Becatecarin N(CH3)2
(DEAE-rebeccamycin) UCN-01 CEP-701
(7-hydroxystaurosporine) (KT-5555) Ruboxistaurin (LY333531)
H2N COOH H
H
N N O
O O
N
H
Tryptophan N N
N N
H (2x)
Cl Cl O
O OH -
H3C H
Cl
O
HO Glucose NH
OH CH3
O CH3
H 3C Methionine
REBECCAMYCIN STAUROSPORINE
7-oxo 7-deoxo
H H
O N O N O
Halogenation
N N N N
Cl H Cl Additional
linkage O
O OH H3C H
D-Glucose O 2,3,6-trideoxy-
HO NH L-sugar
OH CH3
O CH3
H3C
Methylation Amination
Methylations
Gene cluster for rebeccamycin biosynthesis
G O D C P M R F U H T
N N
Cl H Cl
O OH
HO
OH
O
H3C
G O D C P M R F U H T cosmid 14E8
G O D C P M R F U pREB7
H
p O D C P M pREB6 O N O
N N
Cl H Cl
O OH
HO
OH
O
H3C
rebeccamycin
G O D C P M R F U H T cosmid 14E8
G O D C P M R F U pREB7
H
p O D C P M pREB6 O N O
H
O N O N N
Cl H Cl
H
O N O O OH
N N HO
H OH
N N O OH O
H H H3C
dideschloro-rebeccamycin HO rebeccamycin
OH
aglycone O
H 3C
dideschloro-
rebeccamycin
C. Sánchez et al. (2002) Chem. Biol. 9, 519-531
Rebeccamycin biosynthesis: proposed pathway (I-III)
I. Tryptophan modification
NH2 NH2
HOOC HOOC
RebH
RebH
N N
H Cl H
L-tryptophan
Rebeccamycin biosynthesis: proposed pathway (I-III)
II. Dimerization
I. Tryptophan modification
III. Ring closure
RebO H
NH2 NH2 N
HOOC HOOC RebD O O
RebH
RebH
x2
N N
H Cl H RebC N N
H H
L-tryptophan RebP Cl Cl
aglycone
Rebeccamycin biosynthesis: proposed pathway (IV-V)
H
H N
N O O
O O
H
O N O N N
RebG N N RebM
RebG RebM Cl H Cl
Cl H Cl
OH
OH O
N N O
Cl H H Cl HO HO
OH OH
aglycone
OH O
CH3
rebeccamycin
Dissection and reconstitution of the rebeccamycin pathway
rebO
rebD
rebO rebD
- Multiple combinations of reb genes
rebO rebD rebC
rebO rebD rebC rebP rebG rebM - Identification of metabolites (HPLC-MS, NMR)
rebO rebD rebH
H
HOOC NH2 RebO HOOC N COOH
RebD
(2 x)
N N N
H H H
L-tryptophan 1
chromopyrrolic
acid
H
HOOC NH2 RebO HOOC N COOH
RebD
(2 x)
N N N
H H H RebP
L-tryptophan 1
chromopyrrolic H H H
acid O N O N O HO N O
N
H
N
H
+ N
H
N
H
+ N
H
N
H
2 3 4
dideschloro- staurosporine 7-OH-staurosporine
rebeccamycin aglycone aglycone
aglycone
N
H
N
H
+ N
H
N
H
+ N
H
N
H
2 3 4
dideschloro- staurosporine 7-OH-staurosporine
rebeccamycin aglycone aglycone
aglycone
Biosynthesis of rebeccamycin
H H
O N O O N O
H H
HOOC NH2 HOOC N COOH RebC O N O
RebO
RebD RebP RebG RebM
(x 2) N N N N
H Cl H Cl
N N N N N Cl Cl O OH
H H H H H O OH
Cl Cl R Cl R
HO HO
7-chlorotryptophan OH OH
7 R=H 9 R=H OH OCH3
8 R=Cl 10 R=Cl
11 12
RebH
demethyl- REBECCAMYCIN
rebeccamycin
HOOC NH2
N
H Here, co-expression of rebT
L-tryptophan was needed to obtain transformants
N
H
L-tryptophan
H2N O
HOOC NH2 HOOC NH2 O O
O
OH
PyrH Cl NH
OH
NH
N N O
H H N
COOH
O
H
L-tryptophan Cl pyrroindomycin B
5-chlorotryptophan
H
HOOC NH2 HOOC NH2 O N O
RebH
N N
N N Cl H Cl
H H O OH
Cl
HO
L-tryptophan OH
OCH3
7-chlorotryptophan
REBECCAMYCIN
Production of derivatives chlorinated at novel positions
NH
N N OH
H H NH
O
COOH
L-tryptophan O N
5-chlorotryptophan Cl pyrroindomycin B H
1 kb
reb G O D C P M R F U H T
sta R B A N G O D P MA J K I E MB C
REB O
H
N O
Indolocarbazole formation STA H
N O
Sugar attachment
Halogenation
N N N N
Cl H Cl Sugar biosynthesis O
O OH H 3C H
Resistance / Secretion
O
HO Regulation NH
OH CH3
O CH3
H3C
sta R B A N G O D P MA J K I E MB C
Indolocarbazole formation
7-oxo Sugar attachment 7-deoxo H
H N
N O
O O Halogenation
Sugar biosynthesis
Resistance / Secretion
N N
N N Regulation
H O
Cl Cl
H3C H
O OH
H3CO
HO
NHCH3
OH
OCH3
Dissection and reconstitution of the rebeccamycin pathway
N
H
N
H
+ N
H
N
H
+ N
H
N
H
2 3 4
dideschloro- staurosporine 7-OH-staurosporine
rebeccamycin aglycone aglycone
aglycone
rebO rebD H
HOOC N COOH
rebO rebD rebC = chromopyrrolic acid
rebD N N
rebO staC H H
rebO rebD H
HOOC N COOH
rebO rebD rebC = chromopyrrolic acid
rebD N N
rebO staC H H
H H H
HO N O O N O N O
rebO rebD rebP
rebO rebD H
HOOC N COOH
rebO rebD rebC = chromopyrrolic acid
rebD N N
rebO staC H H
H H H
HO N O O N O N O
rebO rebD rebP
H
O N O
rebO rebD rebC rebP
= non-chlorinated rebeccamycin aglycone
rebO rebD rebC staP
N N
H H
H
N O
rebO rebD staC rebP
= staurosporine aglycone
rebO rebD staC staP
N N
H H
Non-halogenated H
N O
H
N O
H
N O
rebO rebD staC rebP
N N N N
H H
O OH O OH
rebO rebD staC rebP rebG N N
H H HO HO
OH OH
3 OH OCH3
rebO rebD staC rebP rebG rebM
13 14
H H
N N
Halogenated O O
H
N
O
O
pETAS staMA staJ staK staI staE staMB
CH3
HO
NH2
HOLYRINE A
H
N
O
N N
H
CH3
HO
NH2
N N
HOLYRINE A NHCH3
H3 C O
staMA staN staMB
H3CO
STAUROSPORINE
N N
NH2
H3 C O
H
N HO
O
staN
N N
H
CH3
HO
NH2
N N
HOLYRINE A NHCH3
H3 C O
staMA staN staMB
H3CO
STAUROSPORINE
N N
staMA NO MODIFICATION
NH2
H3 C O
H
N staMB HO
O
N N
NHCH3
staN
N N H3 C O
H HO
O
staMA staN N N
CH3
NH2
HO H 3C O
NH2
H3CO
staN staMB
N N
HOLYRINE A NHCH3
H3 C O
staMA staN staMB
H3CO
STAUROSPORINE
StaA StaI
(2x)
N N N StaB StaJ
H H H N
H
N
H
StaE StaK
L-Tryptophan Chromopyrrolic acid
K-252c
NDP-L-ristosamine
H
N
O
StaG
StaMA H
StaMB N
O
N N
H H
N NHCH3 N
O O
H 3C O
HO
N N
H
H
N N N N N
NHCH3
O
NH2
StaN O
H 3C O H3 C O
StaMA CH3
H3CO HO
HO
Staurosporine N N StaMB NH2
NH2
H3 C O
Holyrine A
H3CO
Sugar substrate flexibility of StaG and StaN
H
Using a two-plasmid system in Streptomyces albus N
O
pLNBIV
L-digitoxose H3C O
oleV oleW eryBIV oleY oleL oleS oleE HO
CH3
O
D-olivose HO
ole urdR eryBIV HO
α-L-rhamnose
O N
O
N N
pKC39GNT rebO rebD staC rebP staG staN rebT H N N
O OH
H 3C O
CH3 HO
pRHAM oleL oleS oleE oleU OH HO
OH
HO
O
H3 C O
CH3 HO
pLN2 oleV oleW oleU oleY oleL oleS oleE OH
HO
HO
N N α-L-digitoxose
pKC39GNT rebO rebD staC rebP staG staN rebT H
N N
O OH
CH3 H3 C O
pLNR oleV oleW urdR oleY oleL oleS oleE HO
HO
HO
N N
H
pKC39GNT rebO rebD staC rebP staG staN rebT
O
β-D-olivose
H3 C
pLNBIV oleV oleW eryBIV oleY oleL oleS oleE
HO
OH
RebC StaC
H H
O N O N O
N N N N
Cl H Cl StaN StaG
RebH O
H3C H
O OH
O
RebG CH3 NH StaB
HO
OH CH3 StaE
O StaI
H3C StaMB StaJ
RebM StaK
StaMA
César Sánchez
Aaroa P. Salas
Alfredo F. Braña
Carmen Méndez
José A. Salas
University of Oviedo
(Spain)
In collaboration with:
Lili Zhu
Igor A. Butovich
Jürgen Rohr
University of Kentucky
(USA)